Progressive publishes new research

RNS Number : 1961O
Sopheon PLC
28 May 2020
 

Innovation like never before

COVID-19 continues to have a profound impact on virtually every industry, on a global basis.  Enterprises of all types and sizes are racing to adapt their models to the "new normal".  The more thoughtful are looking not just to effect change, but to improve how change happens, to become more flexible and more nimble as organisations.  Sopheon has today announced some major developments to its Accolade platform which look to assist the group's customers in this endeavour.  This note describes the changes to the product range, and draws on a recent customer webinar used by Sopheon to highlight the evolving challenges to enterprise innovation management.

 

Click here for full analysis

 

Subscribe   to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

 

Progressive is an equity research and investor engagement company.  FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts.  We provide Institutional grade research and connect companies with investors across every sector of the market.

 

www.progressive-research.com

 

Broad coverage

 

Analyst calibre

 

across 12 sectors

 

 

 



 

 

 

Business Services

Oil & Gas

15
analysts

with average

20
years

Financials

Property

experience of

Healthcare

Retail


Industrials

Technology

30+


techMARK

Investment Trusts

Telecoms

industry based

Extel

Mining

Utilities

awards

StarMine

 

 

For further information please contact:

 

Emily Ritchie

+44 (0) 20 7781 5311

eritchie@progressive-research.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGLGDUUBDDGGI

Companies

Sopheon (SPE)
UK 100

Latest directors dealings